ProfileGDS4718 / 231163_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 51% 51% 49% 51% 49% 46% 47% 50% 51% 49% 48% 51% 49% 49% 47% 48% 47% 50% 48% 57% 53% 49% 46% 47% 51% 46% 49% 49% 52% 55% 50% 48% 55% 50% 48% 46% 48% 55% 55% 48% 53% 42% 45% 46% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5496751
GSM549102patient 115, normal, homogenized [OPG study]5.611451
GSM549104patient 119, normal, homogenized [OPG study]5.4354349
GSM549108patient 138, normal, homogenized [OPG study]5.6378451
GSM549119patient 077, normal, homogenized [OPG study]5.4689349
GSM549133patient 032, cancer, homogenized [OPG study]5.2243346
GSM549139patient 042, cancer, homogenized [OPG study]5.3277847
GSM549099patient 107, normal, homogenized [OPG study]5.545750
GSM549109patient 139, normal, homogenized [OPG study]5.6007751
GSM549110patient 046, normal, homogenized [OPG study]5.4486249
GSM549114patient 063, normal, homogenized [OPG study]5.3421748
GSM549122patient 082, normal, homogenized [OPG study]5.5590351
GSM549134patient 033, cancer, homogenized [OPG study]5.4317149
GSM549136patient 036, cancer, homogenized [OPG study]5.4060949
GSM549140patient 044, cancer, homogenized [OPG study]5.3088647
GSM549111patient 047, normal, homogenized [OPG study]5.3574948
GSM549113patient 057, normal, homogenized [OPG study]5.3018647
GSM549132patient 031, cancer, homogenized [OPG study]5.5153950
GSM549137patient 038, cancer, homogenized [OPG study]5.4076248
GSM549142patient 047, cancer, homogenized [OPG study]6.0054957
GSM549100patient 110, normal, homogenized [OPG study]5.6780753
GSM549107patient 135, normal, homogenized [OPG study]5.4227149
GSM549115patient 068, normal, homogenized [OPG study]5.2056246
GSM549116patient 072, normal, homogenized [OPG study]5.3024347
GSM549120patient 078, normal, homogenized [OPG study]5.5587851
GSM549131patient 030, cancer, homogenized [OPG study]5.2580946
GSM549118patient 074, normal, homogenized [OPG study]5.4625249
GSM549129patient 027, cancer, homogenized [OPG study]5.4793549
GSM549123patient 088, normal, homogenized [OPG study]5.6168152
GSM549124patient 006, cancer, homogenized [OPG study]5.8382755
GSM549126patient 015, cancer, homogenized [OPG study]5.5036950
GSM549128patient 025, cancer, homogenized [OPG study]5.4136348
GSM549103patient 117, normal, homogenized [OPG study]5.8271755
GSM549117patient 073, normal, homogenized [OPG study]5.4490150
GSM549138patient 041, cancer, homogenized [OPG study]5.3932548
GSM549141patient 045, cancer, homogenized [OPG study]5.262146
GSM549130patient 028, cancer, homogenized [OPG study]5.4180648
GSM549101patient 111, normal, homogenized [OPG study]5.8442355
GSM549105patient 128, normal, homogenized [OPG study]5.8449555
GSM549106patient 134, normal, homogenized [OPG study]5.3789248
GSM549112patient 048, normal, homogenized [OPG study]5.6573853
GSM549125patient 011, cancer, homogenized [OPG study]5.0983642
GSM549127patient 024, cancer, homogenized [OPG study]5.2602745
GSM549135patient 035, cancer, homogenized [OPG study]5.2344246